Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates

Core Viewpoint - Globus Medical reported quarterly earnings of $1.18 per share, significantly exceeding the Zacks Consensus Estimate of $0.79 per share, marking an earnings surprise of +49.37% [1][2] Financial Performance - The company achieved revenues of $769.05 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.85% and showing an increase from $625.71 million year-over-year [2] - Over the last four quarters, Globus Medical has exceeded consensus EPS estimates three times and has also topped revenue estimates three times [2] Stock Performance - Globus Medical shares have declined approximately 25.6% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The current Zacks Rank for Globus Medical is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.89, with expected revenues of $770.15 million, and for the current fiscal year, the estimate is $3.21 on $2.85 billion in revenues [7] - The trend of estimate revisions for Globus Medical was mixed prior to the earnings release, which may change following the recent results [6] Industry Context - The Medical - Instruments industry, to which Globus Medical belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]